NCT01590732 2018-09-19Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomaM.D. Anderson Cancer CenterPhase 1 Completed22 enrolled